Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2012

View Archived Issues

Studies yield encouraging VRS-317 pharmacodynamic and safety data

Pfizer immunotherapeutic for inflammatory diseases shows promise in phase I trials

Epicutaneous patch for peanut allergy safe and effective in patients

Michael J. Fox Foundation extends support to biomarker research program

Insmed doses first patient in TARGET-NTM trial

Investigators in Israel design new mouse model of familial dysautonomia

Vorinostat in combination with bortezomib: Final results from VANTAGE trials

FDA approves Astellas drug for overactive bladder

Anthera updates phase III blisibimod plans

Gilead submits NDA for elvitegravir

Merrimack adds third arm to phase III trial in metastatic pancreatic cancer

FDA grants priority review to NDA for regorafenib

Novel PARP inhibitors developed in China

New formylpeptide receptor ligands patented by Allergan

Lilly presents novel MAP kinase p38 inhibitors

Research at Pfizer yields novel potential antibacterial drugs

New notum-directed antibodies may be useful to treat osteoporosis

Novel potential cancer immunotherapy designed in Korea

Synta reports on interim analysis of GALAXY trial

FDA accepts Shionogi NDA for review

Sanwa and Fuji submit application for hyperuricemia and gout treatment in Japan

Compugen shows potential of another B7/CD28-like protein target

SymBio opens enrollment in Japanese rigosertib trial

Astellas' Gonax approved in Japan

Vertex Pharmaceuticals announces final phase II data on VX-809/Kalydeco combination

Oxis Turbuhaler approved in Japan in different formulations

Eisai and Toyama Chemical obtain approval in Japan for rheumatoid arthritis drug

Japanese authorities approve Inlyta tablets

Mitsubishi Tanabe drug approved for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...